191 related articles for article (PubMed ID: 16761245)
21. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
23. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
Van de Moere A; Sandhu SS; Kak R; Mitchell KW; Talks SJ
Ophthalmology; 2005 Nov; 112(11):1896-903. PubMed ID: 16214216
[TBL] [Abstract][Full Text] [Related]
24. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
25. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
Retina; 2006; 26(9):988-93. PubMed ID: 17151484
[TBL] [Abstract][Full Text] [Related]
26. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Lazic R; Gabric N
Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.
Rosenblatt BJ; Shah GK; Blinder K
Retina; 2005 Jan; 25(1):33-7. PubMed ID: 15655438
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
Ladd BS; Solomon SD; Bressler NM; Bressler SB
Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
[TBL] [Abstract][Full Text] [Related]
30. Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration.
Lie S; Aue A; Sacu S; Simader C; Polak K; Schmidt-Erfurth U
Acta Ophthalmol; 2010 Mar; 88(2):212-7. PubMed ID: 19016662
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
Ho TC
Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
[No Abstract] [Full Text] [Related]
32. Prolongation of choroidal hypofluorescence following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetonide injection.
Luttrull JK; Spink CJ
Retina; 2007; 27(6):688-92. PubMed ID: 17621176
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
[TBL] [Abstract][Full Text] [Related]
34. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
Augustin AJ; Puls S; Offermann I
Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193
[TBL] [Abstract][Full Text] [Related]
35. Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.
Yip PP; Woo CF; Tang HH; Ho CK
Br J Ophthalmol; 2009 Jun; 93(6):754-8. PubMed ID: 19273471
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
[TBL] [Abstract][Full Text] [Related]
37. Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.
van de Moere A; Kak R; Sandhu SS; Talks SJ
Am J Ophthalmol; 2007 Apr; 143(4):701-4. PubMed ID: 17386286
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
39. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
[TBL] [Abstract][Full Text] [Related]
40. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone.
Michels S; Aue A; Simader C; Geitzenauer W; Sacu S; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Feb; 141(2):396-398. PubMed ID: 16458709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
